IL17F and colorectal carcinoma: We have also found a positive link between IL17F polymorphism, a chemotherapy (p = 0,011 RR 0,7 (0,62–0,89)) and a surgery (P = 0,023 RR 0,76 (0,62–0,93)) in CRC patients with a late stage (Table 5).